INTRODUCTION
In many situations, such as in medical research, sample sizes may not be previously known. This often occurs when there is a specific time span for collecting the observations. The aim of this paper is to extend one-way random effects models to those situations and apply our results to a Brazilian database on cancer registries.
In these situations it is more correct to consider the samples sizes as realizations n 1 , ..., n r of independent random variables N 1 , ..., N r , see [2, 3, 4, 5, 6, 7] . We assume that these random variables will be independent Poisson distributed with parameters λ 1 ,...,λ r . Therefore n = ∑ r i=1 n i will be a realization of the random variable N = ∑ r i=1 N i which is Poisson distributed with parameter λ = ∑ r i=1 λ i , see [2, 6, 7] . When N i = n i , i = 1,...,r, the one-way random effects model can be written as, see e.g. [8] ,
where μ is a fixed unknown parameter and α i and e i, j , j = 1, ..., n i , i = 1, ..., r, are independent normal variables with null mean values and variances, respectively, σ 2 α and σ 2 ,
.., r. The model (1) can be written in matrix notation as, see e.g. [1] ,
where
.., α r ) and D(1 1 1 n 1 , ...,1 1 1 n r ) denotes a block diagonal matrix with 1 1 1 n 1 , ...,1 1 1 n r along the blocks and 1 1 1 m is the vector with all m components equal to 1. Therefore, α α α and e e e are normal distributed, with null mean vectors and variance-covariance matrices, respectively, σ 2 α I I I r and σ 2 I I I n , α α α ∼ N(0 0 0, σ 2 α I I I r ), e e e ∼ N(0 0 0, σ 2 I I I n ), with I I I n the n × n identity matrix. The vector Y Y Y , when N = n, will be conditionally normal with mean vector μ μ μ = μ1 1 1 r and variance-covariance matrix given by, see [1] and [9] 
We are interested in test the hypotheses
In what follows we present the test statistic for testing these hypotheses and their conditional and unconditional distributions. We will consider the expression of the test statistic obtained in [5] . Then we present an application based on real medical data, particulary on cancer registries from São Paulo, Brazil. Finally we conclude with some final remarks.
STATISTIC AND THEIR DISTRIBUTIONS
In this section we will obtain the common conditional distribution of the test statistic and also it's unconditional distribution, under the assumption that we have a global minimum dimension for the samples, which avoids highly unbalanced cases.
The sum of squares for the error will be given by, see e.g. [9] ,
with
.., r and S will be the product by σ 2 of a central chi-square with g(n) = n − r degrees of freedom, S ∼ σ 2 χ 2 g(n) . As we can see, for instance in [9] , S can be written using the matrix formulation as
When N i = n i , the sample means
have mean values μ and variances σ 2 α + σ 2 n i
, i = 1,...,r. So, when the hypothesis H 0 holds,
Let us consider
and
.., r, Z Z Z will be normal distributed with null mean vector and variance-covariance matrix
The sum of squares for the main effects of the factor will be given by
with g = rank(V V V ) = r − 1, see [5] . Therefore, when N = n and H 0 holds, the common conditional distribution of the test statistic
will be F(.|g, g(n)), which is the distribution of the quotient of independent central chi-squares with g and g(n) degrees of freedom.
For carrying out the inference we assume that N ≥ n • , which means that we assume that we have a global minimum dimension for the samples, see [2, 5, 6, 7] . So we take
and we obtain the unconditional distribution given by As we saw, given N = n, the conditional distribution of ℑ is, when H 0 holds, a central F distribution with g = 5 and g(n) = n − 6 degrees of freedom, F(.|5, n − 6).
To carry out the calculations when we may assume that ∑ n • −1 n=0 p n • (n) 0, which means that, with high probability, we have N ≥ n • , the unconditional distribution of the statistic will be given by
Moreover, to the monotony property of the F distribution, see [2] , we have F(z|g, n − 6) < F(z|g, n o − 6), with n < n o , so
which gives us a lower bound for F(z). Thus, from F(z|5, n • − 6), we can obtain upper bounds for the quantiles of the unconditional distribution F(z). If we use these upper bounds as critical values we will have tests with sizes that do not exceed the theoretical values.
If the statistic's value exceeds the upper bounds, also exceeds the real critical value (obtaining considering random sample sizes) and in this case we reject the hypothesis. When the statistic's value is lower than the upper bound we must compute the real critical values or calculate the minimum value of n • that leads to reject the null hypothesis.
In this case we obtain If we use the common conditional distribution of ℑ, which corresponds to F(z|5, 683), we will obtain the quantiles, z 1−α , given in Table 2 . So, since ℑ Obs > z 1−α , we can conclude that we reject H 0 for the usual levels of significance.
Let us now assume that n • = 59, which means that we have about 10 observations per treatment. The Table 2 shows the upper bounds for the quantiles, z u 1−α , for probability 1 − α of the unconditional distribution F(z). The results in this table may lead us to take a contrary decision that we had taken using the conditional distribution of the statistics for α = 0.05 and α = 0.01. Therefore the increase of the critical values points towards the possibility of non-rejection when random sample sizes are considered. Assuming the values of the test statistic remain unchanged, for ensuring rejection, we should have the total sample sizes presented in Table 3 . Since for higher values of n • we would get lower values for the quantiles, we have ℑ Obs > z u 1−α for all n • ≥ 79, which means that, in this case, we reject H 0 considering the usual levels of significance. Thus the kind of cancer has a significant random effect, so the ages of disease detection may differ significantly with it's kind.
FINAL REMARKS
When we cannot previously know the sample sizes it is much more correct to consider them as realizations of random variables. Through the application on cancer registries we can prove the relevance of the unconditional approach in order to possibly avoid false rejections. We also can conclude that when the samples dimensions increase, the conditional and unconditional approach converge to the same decision.
During our treatment we worked with F distributions since they are more treatable and statistically equivalent. This equivalence enabled us to consider our tests as F-tests.
